ArticleTranscultural psychiatry2016
Shifting blame: Buprenorphine prescribers, addiction treatment, and prescription monitoring in middle-class America.
Article in Transcultural psychiatry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Nurse prescribing right: a bibliometric analysis.Frontiers in medicine · 2025Pooled it
- A systematic review of patients' and providers' perspectives of medications for treatment of opioid use disorder.Journal of substance abuse treatment · 2020Pooled it
- "The alternative is they're not getting care at all": a qualitative interview study of opioid use disorder treatment providers' perspectives on quality and appropriateness of telehealth for buprenorphine access.Harm reduction journal · 2026Article
- Treatment preferences of patients receiving opioid agonist therapy in spain: a discrete choice experiment.Addictive behaviors reports · 2026Article
- Assessing buprenorphine treatment utilization and SAMHSA DATA waiver provider distribution in 2021: a real-world analysis in California.Scientific reports · 2025Article
- Cross-sectional examination of characteristics of higher-dose buprenorphine prescriptions during the era of illicit fentanyl.Addiction science & clinical practice · 2025Article
- Facilitators of and barriers to buprenorphine initiation in the emergency department: a scoping review.Lancet regional health. Americas · 2024Article
- A survey of barriers and facilitators to the adoption of buprenorphine prescribing after implementation of a New Jersey-wide incentivized DATA-2000 waiver training program.BMC health services research · 2024Article
- Buprenorphine for Chronic Pain Management: a Narrative Review.Current pain and headache reports · 2023Review
- Expanding Buprenorphine Use in Primary Care: Changing the Culture.The Permanente journal · 2022Article
- Survey of Barriers and Facilitators to Prescribing Buprenorphine and Clinician Perceptions on the Drug Addiction Treatment Act of 2000 Waiver.JAMA network open · 2022Article
- Support for evidence-informed opioid policies and interventions: The role of racial attitudes, political affiliation, and opioid stigma.Preventive medicine · 2022Article
- Evaluating buprenorphine prescribing and opioid-related health outcomes following the expansion the buprenorphine waiver program.Journal of substance abuse treatment · 2022Article
- Advancing Health Equity in Digital Mental Health: Lessons From Medical Anthropology for Global Mental Health.JMIR mental health · 2021Article
- Primary care physicians' preparedness to treat opioid use disorder in the United States: A cross-sectional survey.Drug and alcohol dependence · 2021Article
- Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.Journal of substance abuse treatment · 2020Article
- Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.NAM perspectives · 2020Review
- Depot Buprenorphine Injection In The Management Of Opioid Use Disorder: From Development To Implementation.Substance abuse and rehabilitation · 2019Review
- Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment.American journal of preventive medicine · 2018Article
- The War on Drugs That Wasn't: Wasted Whiteness, "Dirty Doctors," and Race in Media Coverage of Prescription Opioid Misuse.Culture, medicine and psychiatry · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Growing nonmedical prescription opioid analgesic use among suburban and rural Whites has changed the public's perception of the nature of opioid addiction, and of appropriate interventions. Opioid addiction has been recast as a biological disorder in which patients are victims of their neurotransmitters and opioid prescribers are irresponsible purveyors of dangerous substances requiring controls. This framing has led to a different set of policy responses than the "War on Drugs" that has focused on heroin trade in poor urban communities; in response to prescription opioid addiction, prescription drug monitoring programs and tamper-resistant opioid formulations have arisen as primary interventions in place of law enforcement. Through the analysis of preliminary findings from interviews with physicians who are certified to manage opioid addiction with the opioid pharmaceutical buprenorphine, we argue that an increase in prescriber monitoring has shifted the focus from addicted people to prescribers as a threat, paradoxically driving users to illicit markets and constricting their access to pharmaceutical treatment for opioid addiction. Prescriber monitoring is also altering clinical cultures of care, as general physicians respond to heightened surveillance and the psychosocial complexities of treating addiction with either rejection of opioid dependent patients, or with resourceful attempts to create support systems for their treatment where none exists.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.